Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? A Randomized, Double-blinded, Placebo-controlled Clinical Trial

NCT01845259 is registered in ClinicalTrials.gov with Psychiatric Centre Rigshospitalet as lead sponsor.

NCT NCT01845259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? A Randomized, Double-blinded, Placebo-controlled Clinical Trial
Lead sponsor
Psychiatric Centre Rigshospitalet
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2013
Completion date
March 31, 2017
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired glucose tolerance associated with drugs